China’s stock market nears low of 2015 crash after drug makers slide amid Beijing crackdown on industry
Regulator vows to clean up health care industry after vaccine scandal, sending shares of biopharmaceutical companies tumbling
China’s stocks dropped for a fifth day, nearing the low of the 2015 market rout, as Beijing vowed to clean up the health care sector in the wake of a vaccine scandal and concerns deepened about a slowdown in growth.
The Shanghai Composite Index slid 1.3 per cent on Friday, ending the week with a 4.5 per cent decline.
That is just 0.5 per cent shy of the nadir set in January 2015 after the rout that erased US$5 trillion in market value.
In contrast, Hong Kong’s Hang Seng Index rose for the first time after five days of losses, ending up 0.4 per cent.
Selling in the mainland equity markets accelerated in the afternoon session, with Shenzhen Kangtai Biological Products and other biopharmaceutical companies bearing the brunt of the hammering.